Formulation and In Vitro Evaluation of Furosemide Floating Matrix Tablets Using Boswellia papyrifera Resin as Matrix Forming Polymer

Table 1

Composition of formulated tablets.

Form. code	Ingredients (% w/w)
	API	Resin	HPMC K4M	NaHCO3	Lactose	Talc	Mg-stearate
B1	14.3	10	—	10	63.7	1	1
B2	14.3	40	—	10	33.7	1	1
B3	14.3	—	10	10	63.7	1	1
B4	14.3	—	40	10	33.7	1	1
B5	14.3	5	5	10	63.7	1	1
B6	14.3	2.5	7.5	10	63.7	1	1
B7	14.3	7.5	2.5	10	63.7	1	1
B8	14.3	20	20	10	33.7	1	1
B9	14.3	10	30	10	33.7	1	1
B10	14.3	30	10	10	33.7	1	1
B11	14.3	40	—	20	23.7	1	1
B12	14.3	—	40	20	23.7	1	1